Skip to main content
Contact Us
Subscribe
E-Edition
83°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Eli Lilly and Co
Recent news which mentions Eli Lilly and Co
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Today 4:24 EDT
Tags
Health care industry
Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
September 17, 2024
Tags
Health & Science
Health care industry
Healthy Returns
From
CNBC.com News
Drugmakers bet billions that targeted radiation could become the next cancer breakthrough
September 16, 2024
Tags
Biotech and Pharmaceuticals
Eli Lilly and Co
Bristol/Myers Squibb Co
From
CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
September 12, 2024
Tags
Eli Lilly and Co
US: News
Business News
From
CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
September 10, 2024
Tags
Biotech and Pharmaceuticals
Social issues
Apple Inc
From
CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
September 05, 2024
Tags
Health & Science
Healthy Returns
Abbott Laboratories
From
CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
September 02, 2024
Tags
Eli Lilly and Co
Novo Nordisk A/S
Business News
From
CNBC.com News
CNBC Daily Open: Everyone's waiting for Nvidia
August 28, 2024
Tags
World Markets
Crude oil markets
Medication
From
CNBC.com News
CNBC Daily Open: Stocks up ahead of Nvidia earnings
August 27, 2024
Tags
Market Outlook
Asia Markets
Semiconductor device manufacturing
From
CNBC.com News
5 things to know before the stock market opens Tuesday
August 27, 2024
Tags
Economy
Paramount Global
Business News
From
CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
August 27, 2024
Tags
Eli Lilly and Co
US: News
Novo Nordisk A/S
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
August 22, 2024
Tags
Stock markets
Equity Residential
Aflac Inc
From
CNBC.com News
CNBC Daily Open: A 'crazy' summer
August 21, 2024
Tags
Money markets
Asia News
Economy
From
CNBC.com News
CNBC Daily Open: 'Crazy' summer
August 20, 2024
Tags
Money markets
Asia News
Autos
From
CNBC.com News
Wednesday's big stock stories: What's likely to move the market in the next trading session
August 20, 2024
Tags
Netflix Inc
Macy's Inc
Investment strategy
From
CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
August 20, 2024
Tags
Health & Science
Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Merck & Co Inc
Novo Nordisk A/S
US: News
From
CNBC.com News
Thursday's big stock stories: What’s likely to move the market in the next trading session
August 14, 2024
Tags
Pultegroup Inc
Nasdaq Inc
stocks
From
CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
August 14, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health care industry
From
CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
August 13, 2024
Tags
US: News
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
After Eli Lilly's blowout quarter, Cramer says not to get too caught up in macro market trends
August 08, 2024
Tags
Business News
Business
Investment strategy
From
CNBC.com News
Eli Lilly blows past estimates, hikes guidance as Zepbound, Mounjaro sales soar
August 08, 2024
Tags
Health care industry
Breaking News: Earnings
Business
From
CNBC.com News
Thursday's big stock stories: What's likely to move the market in the next trading session
August 07, 2024
Tags
Ulta Beauty Inc
Capri Holdings Ltd
Dollar Tree Inc
From
CNBC.com News
5 things to know before the stock market opens Monday
August 05, 2024
Tags
CrowdStrike Holdings Inc
Business News
Economy
From
CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Breaking news
Companies
Health care industry
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Health care industry
Business
Companies
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Augmedix Inc
Viking Therapeutics Inc
Health & Science
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Biotech and Pharmaceuticals
Biotechnology
Breaking News: Business
From
CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
July 29, 2024
Tags
Eli Lilly and Co
Novo Nordisk A/S
Business News
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Biotechnology
Biotech and Pharmaceuticals
Eisai Co Ltd
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.